SA Shurtleff
- Hematology top 2%
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
- Genetics top 10%
-
- Acute Lymphoblastic Leukemia research 4
- Pathology and Forensic Medicine top 10%
-
- Retinoids in leukemia and cellular processes 2
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 1
- RNA modifications and cancer 1
-
- Sarcoma Diagnosis and Treatment 1
- Partner nations
- United StatesCanada
In The Last Decade
SA Shurtleff
9 papers receiving 691 citations
Peers
Comparison fields: 5 of 41
- Hematology 377
- Genetics 117
- Public Health, Environmental and Occupational Health 311
- Pathology and Forensic Medicine 150
- Oncology 144
Countries citing papers authored by SA Shurtleff
This map shows the geographic impact of SA Shurtleff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SA Shurtleff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SA Shurtleff more than expected).
Fields of papers citing papers by SA Shurtleff
This network shows the impact of papers produced by SA Shurtleff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SA Shurtleff. The network helps show where SA Shurtleff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside SA Shurtleff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 72 | |
| 2 | 1999 | 60 | |
| 3 | Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia. | 1996 | 23 |
| 4 | 1996 | 47 | |
| 5 | 1995 | 8 | |
| 6 | 1995 | 122 | |
| 7 | 1995 | 77 | |
| 8 | 1995 | 142 | |
| 9 | 1994 | 155 |
About SA Shurtleff
SA Shurtleff is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology, having authored 9 papers that have together received 706 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Retinoids in leukemia and cellular processes (2 papers), Epigenetics and DNA Methylation (2 papers), Glycosylation and Glycoproteins Research (1 paper), RNA modifications and cancer (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (377 citations), Genetics (117 citations) and Public Health, Environmental and Occupational Health (311 citations). SA Shurtleff has collaborated with scholars based in United States and Canada. Frequent co-authors include SC Raimondi, C-H Pui, DR Head, F G Behm, J R Downing, Raul C. Ribeiro, David R. Head, FG Behm, JR Downing and M L Hancock. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Cytogenetic and Genome Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.